About us

ECOGENE-21 is a Canadian non-profit organization focused on the patient, committed to revolutionizing access to innovations in precision medicine to meet unmet health needs.

As a renowned biocluster, we have developed a robust clinical research infrastructure, recognized expertise in biobanking, advanced R&D capabilities, and a strong academic component appreciated within the scientific community. Our specialization includes rare diseases or severe common diseases, particularly in the areas of lipid diseases and associated cardiometabolic risks.

OUR mission

Innovation in Diagnostics and Treatment: We provide the possibility to patients to benefit from cutting-edge diagnostics tools and treatments to improve the quality of care through the CTRC network (Clinical and Translational Research Center) and SMASH (System and Molecular Approaches of Severe Hyperlipidemias).
Support for Clinical Research: We facilitate clinical research through specialized digital tools, like our SMART Applications Suite, which optimize processes and outcomes.
Education and Information: We develop educational tools, such as Lipidea, to educate patients, general practitioners, and specialists about the latest advancements in treating lipid diseases.
Academic Support: We are committed to providing the necessary resources for the development of promising academic careers among young researchers and the training of graduate students at the University of Montreal.
Accessibility of Clinical Trials: We innovate to make clinical trials accessible to patients in remote or mobility-restricted areas, including with drones.

At ECOGENE-21, we dedicate ourselves to transforming precision medicine to effectively meet the most complex challenges of modern health. Join us in our mission for a healthier and more sustainable future.